Versiti and Vitrafy Life Sciences Ltd announced a collaboration to evaluate Vitrafy’s next-generation cryopreservation technology for blood products, beginning with an initial focus on platelets.

The collaboration brings together Versiti’s expertise across blood collection, transfusion medicine, research and laboratory services with Vitrafy’s proprietary cryopreservation ecosystem. The organizations plan to conduct proof-of-concept and work designed to evaluate how the technology could be incorporated into blood product workflows and support future clinical and regulatory development.

Vitrafy has developed an integrated cryopreservation ecosystem that combines controlled freezing technology with software designed to support the preservation and management of biological materials. The Versiti collaboration builds on Vitrafy’s ongoing work evaluating the technology for blood components and will initially focus on assessing its application to platelet preservation.

Based on the results of the initial work, the organizations may consider further development activities and evaluation of the technology for additional blood-derived products.

Visit Versiti for more information